Microbes or danger signals trigger inflammasome sensors, which induce polymerization of the adaptor ASC and the assembly of ASC specks. ASC specks recruit and activate caspase-1, which induces maturation of the cytokine interleukin 1b (IL-1b) and pyroptotic cell death. Here we found that after pyroptosis, ASC specks accumulated in the extracellular space, where they promoted further maturation of IL-1b. In addition, phagocytosis of ASC specks by macrophages induced lysosomal damage and nucleation of soluble ASC, as well as activation of IL-1b in recipient cells. ASC specks appeared in bodily fluids from inflamed tissues, and autoantibodies to ASC specks developed in patients and mice with autoimmune pathologies. Together these findings reveal extracellular functions of ASC specks and a previously unknown form of cell-to-cell communication.
The activation of most signaling receptors of the innate immune system results in the induction of gene-transcription programs that lead to the production and release of inflammatory mediators via the secretory pathway 1 . In contrast, the inflammasomes operate on a post-translational level. Inflammasomes trigger the proteolytic maturation of biologically inactive precursors of the interleukin 1β (IL-1β) family of cytokines and mediate the release of these active cytokines from the cytosol 2 . After detecting microbial substances or danger signals, the inflammasome sensor molecules, such as AIM2 or NLRP3, induce rapid polymerization of the bipartite adaptor ASC ('apoptosis-associated speck-like protein containing a caspaserecruitment domain'; also known as PYCARD) into large helical filaments by facilitating self-interactions of the pyrin domains of ASC. The caspase-recruitment domain of ASC then assembles to nucleate the polymerization and filament formation of pro-caspase-1, which leads to its self-activation [3] [4] [5] [6] . Active caspase-1 in turn induces maturation of cytokines of the IL-1 family and also mediates their release into the extracellular space 4, 7 . By forming large filamentous signaling platforms within the cytosol of cells, ASC can provide a scaffold for the optimal recruitment and activation of caspase-1 and thereby trigger a decisive on-off signaling response 8 . The inflammasome sensor NLRC4, which recognizes flagellin and components of type III secretion systems, lacks a pyrin domain and can activate caspase-1 via direct self-interactions of caspase-recruitment domains. Nevertheless, ASC still forms specks upon activation of NLRC4 and enhances the activation of caspase-1 and IL-1β 9, 10 . Active caspase-1 also regulates the noncanonical release of many other proteins and triggers the inflammatory form of cell death called 'pyroptosis' 11, 12 . The activation of inflammasomes results in the maturation of highly proinflammatory cytokines and the death of the activated cell. Hence, such activation is thought to occur only if a potentially harmful inflammatory response is warranted, such as after tissue damage or persistent cellular invasion by bacteria or viruses. The release of IL-1 cytokines leads to the rapid recruitment of neutrophils and monocytes to the site of danger, which is important for limiting the spread of infection and for the initiation of repair after tissue damage 11 . Since the activation of inflammasomes results in pyroptotic cell death and thereby the release of cytoplasmic contents, it is conceivable that ASC specks could ultimately be found in the extracellular environment 13 .
Here we found that ASC specks were released from cells in which inflammasomes were activated and accumulated in the extracellular space. Extracellular ASC specks retained their ability to mature pro-IL-1β even after the demise of the activated cell. Extracellular ASC specks were ingested by macrophages, which resulted in lysosomal damage and IL-1β production in these cells. In mice, injection of ASC specks caused acute inflammatory reactions. Moreover, we detected extracellular ASC specks after experimental activation of inflammasomes in vivo and in bronchoalveolar lavage fluid (BALF) from A r t i c l e s mice and patients with inflammatory airway pathologies. Finally, autoantibodies to ASC specks developed in a small fraction of patients and mice with autoimmune pathologies, and these autoantibodies were able to increase the uptake of ASC specks by macrophages and boost IL-1β activation. Together our results identify extracellular ASC specks as an endogenous danger signal that can perpetuate inflammatory responses.
RESULTS

Accumulation of extracellular ASC specks after pyroptosis
To visualize the activation of inflammasomes, we generated mouse macrophage reporter cells stably expressing ASC fused to a fluorescent protein (ASC-FP) 14 . ASC-FP was evenly distributed in resting cells ( Fig. 1a and Supplementary Movie 1) , consistent with published reports of its soluble cytosolic distribution 3, 4 . After activation of inflammasomes, ASC-FP redistributed to form a paranuclear protein speck in activated cells ( Fig. 1a and Supplementary Movie 1) , consistent with the ability of ASC to rapidly oligomerize after activation of inflammasomes [3] [4] [5] [6] . Immunofluorescence staining with antibody to ASC (anti-ASC) revealed that endogenous ASC also formed specks after activation of inflammasomes in human peripheral blood mononuclear cells and human THP-1 monocytic cells ( Supplementary  Fig. 1a ). We next activated the NLRC4 inflammasome in vivo by injecting Pseudomonas aeruginosa (P. aeruginosa) into the footpads of mice. Ex vivo staining of permeabilized sections from popliteal lymph nodes of these mice revealed the appearance of ASC specks in subcapsular macrophages (Fig. 1b) . These data indicated that the formation of ASC specks was a physiological cellular response to the activation of inflammasomes. Notably, confocal microscopy of ASC-FP-expressing mouse reporter macrophages and ASC-FP-expressing THP-1 human reporter monocytes also revealed the presence of ASC specks in the extracellular space following the activation of inflammasomes ( Fig. 1c,d and Supplementary Movies 2 and 3). ASC specks are protein aggregates of considerable size (~1 µm in diameter) and therefore their appearance in cell-free supernatants can be readily quantified by flow cytometry. Using this technique, we observed a time-dependent accumulation of ASC specks in supernatants of ASC-FP-expressing THP-1 reporter cells after activation of inflammasomes ( Fig. 1e) . To confirm the accumulation of ASC specks in cell-free supernatants after activation of inflammasomes, we did a biochemical analysis of ASC aggregation. We were able to separate ASC specks from nuclei and other dead cell debris in supernatants of activated cells by a combination of centrifugation and filtration with 5-µm filters that retain nuclei but allow the smaller ASC specks to pass 4 (Supplementary Fig. 1b ). By this method, we generated cellfree supernatants of resting cells or cells in which inflammasomes were activated, then chemically crosslinked ASC with disuccinimidyl suberate (DSS) in these supernatants prior to assessing its aggregation by immunoblot analysis for ASC. This method confirmed the presence of not only monomeric species of ASC (~22 kilodaltons in size), but also dimers, trimers and higher order oligomers ( Fig. 1f) . To investigate whether the activation of other inflammasomes can also trigger the accumulation of ASC specks in cell-free supernatants, we treated cells with poly(dA:dT) or anthrax lethal toxin to activate the AIM2 inflammasome or NLRP1 inflammasome, respectively. ASC specks accumulated in cell-free supernatants of cells in which the NLRP1, NLRP3 and AIM2 inflammasomes were activated ( Fig. 1g,h) . These data showed that activation of all the inflammasomes we tested led to the accumulation of ASC specks in the extracellular space.
We next assessed whether the accumulation of extracellular ASC specks is a result of inflammasome-mediated cell death. Indeed, the appearance of extracellular ASC specks in cell-free supernatants correlated with the release of lactate dehydrogenase from activated cells ( Fig. 1i) . Consistent with the induction of cell death after activation of inflammasomes and the proposal that destabilization of the plasma membrane is a key feature of pyroptotic cell death 11 , ASC-FP-expressing reporter macrophages failed to exclude propidium iodide shortly after the formation of ASC specks triggered by the activation of inflammasomes ( Fig. 1j and Supplementary Movie 4) . Thus, ASC specks were probably not actively released but instead remained in the extracellular space after cellular demise. However, since pyroptosis also induces membrane disintegration, it is conceivable that extracellular fluid might also have access to ASC specks shortly after pyroptotic cell death. To test this hypothesis, we added antibody to green fluorescent protein (anti-GFP) directly conjugated to Alexa Fluor 555 to the supernatants and activated NLRP3 in ASC-FP-expressing reporter cells. Live-cell time-lapse microscopy showed that fluorescent anti-GFP positively stained ASC-FP specks shortly after their appearance in activated cells ( Fig. 1k and Supplementary Movie 5). Hence, these data confirmed that the formation of ASC specks preceded cell death and that extracellular fluid promptly gained access to ASC specks within remnants of pyroptotic cells.
ASC specks remain active in the extracellular space
Since the accumulation of ASC specks in cell-free supernatants of cells in which inflammasomes were activated correlated with cell death, we next investigated whether caspase-1 is required for this process. By flow cytometry, we found that the accumulation of ASC specks in cell-free supernatants obtained from cells after activation of inflammasomes was much lower in caspase-1-deficient (Casp1 −/− ) ASC-FP-expressing macrophages than in wild-type ASC-FP-expressing cells ( Fig. 2a) . Similarly, we did not detect the accumulation of ASC specks in supernatants of wild-type ASC-FP-expressing macrophages in which inflammasomes were activated and caspase-1 activity was inhibited with z-YVAD-fmk ( Fig. 2b) . We used DSS to crosslink ASC in filtered cell-free supernatants and in lysates of resting macrophages or in macrophages in which inflammasomes were activated. We then assessed ASC by immunoblot analysis and confirmed that caspase-1 activity was dispensable for the formation of ASC specks in cells, yet it was required for the accumulation of ASC specks in cell-free supernatants ( Fig. 2c) .
To assess the formation ASC specks from endogenous sources and to monitor the extracellular accumulation of ASC specks after activation of inflammasomes, we stimulated wild-type, ASC-deficient (Pycard −/− ; called 'Asc −/− ' here), NLRP3-deficient (Nlrp3 −/− ) or Casp1 −/− macrophages with lipolysaccharide (LPS) and ATP. We then isolated endogenous ASC specks from either cell-free supernatants or cell pellets of the activated cells and probed for ASC and NLRP3 by immunoblot analysis. We found that endogenous ASC specks assembled in wild-type and in Casp1 −/− cells but not in Nlrp3 −/− cells ( Supplementary Fig. 2a ), consistent with the fact that NLRP3 signaling is upstream of ASC. However, we detected the accumulation of ASC specks in cell-free supernatants of wild-type macrophages but not in Casp1 −/− macrophages in which inflammasomes were activated ( Supplementary Fig. 2a ). Together these findings confirmed that caspase-1-mediated cell death was required for the accumulation of extracellular ASC specks formed from endogenous ASC.
We hypothesized that one function of extracellular ASC specks might be to promote further processing of caspase-1 and IL-1β in the extracellular space. Indeed, it is known that pro-caspase-1 and pro-IL-1β can accumulate in supernatants of macrophages in which inflammasomes are activated 15, 16 and thus it appeared plausible that npg ASC specks might further promote the maturation of caspase-1 and IL-1β. Fluorescent ASC specks spontaneously assembled upon heating of cytosolic extracts to 37 °C, which allowed us to prepare recombinant ASC specks from macrophages 4 (Supplementary Fig. 2b) . Immunoblot analysis and flow cytometry revealed that these recombinant ASC specks contained NLRP3, ASC and caspase-1 ( Supplementary  Fig. 2c,d) . Furthermore, confocal microscopy of antibody-stained endogenous proteins in activated THP-1 monocytes confirmed that both extracellular ASC specks and intracellular ASC specks contained both NLRP3 and ASC ( Supplementary Fig. 2e ). NLRP3 was present in the core of the endogenously formed ASC specks ( Supplementary  Fig. 2e,f) , similar to published findings obtained with inflammasomes reconstituted in vitro with purified proteins 5 . Of note, microscopy of cells in which inflammasomes were activated revealed that only a portion of the NLRP3 was associated with ASC specks, although all cellular ASC was recruited to the speck (Supplementary Fig. 2f ). To determine whether ASC specks can activate pro-IL-1β or pro-caspase-1 in cell-free systems, we next isolated cytosols from LPS-primed Asc −/− (e) Flow cytometry assessing the size (forward scatter (FSC-A)) and granularity (side scatter (SSC-A)) of cell-free supernatants of LPS-primed, nigericin-activated ASC-mCerulean-expressing THP-1 monocytes (far left) and extracellular ASC-mCerulean specks (CFP-A) in those supernatants (middle left). Numbers in plot (far left) indicate diameter of beads used for scatter reference; outlined area indicates gating of ASC-mCerulean specks used for quantification of extracellular specks (CFP-A) in cell-free supernatants of ASC-mCeruleanexpressing THP-1 monocytes left untreated (−) or primed for 2 h with LPS (1 µg/ml) and activated for 30, 60 or 120 min (above plots) with nigericin (10 µM) (LPS + nig) (right; three technical replicates (Reps 1-3, key)). (f) Immunoblot analysis (IB) of endogenous ASC, with (+DSS) or without (−DSS) crosslinking by DSS (below blot), in cell pellets of wild-type THP-1 monocytes left untreated (−) or treated as in d (+) (Pellet), and in their cell-free supernatants filtered through 5-µm filters (Filtrate). Right margin, molecular size, in kilodaltons (kDa). (g,h) Quantification of extracellular specks (g) and immunoblot analysis of ASC (h) in macrophages primed for 3 h with LPS (250 ng/ml) and then left untreated (−) or treated with nigericin (Nig), poly(dA:dT) or lethal toxin. β-actin (h) serves as a loading control throughout. sup, supernatant. (i) Extracellular ASC specks and lactate dehydrogenase (LDH) in cell-free supernatants of LPS-primed ASC-mCerulean-expressing THP-1 monocytes left inactivated (−) or activated with nigericin for 30, 60 or 120 min (horizontal axis). npg macrophages and incubated them at 37 °C in presence or absence of recombinant ASC specks purified from ASC-FP-expressing cells. This analysis showed that processing of pro-caspase-1 and pro-IL-1β into their mature forms occurred only in Asc −/− cytosols incubated with ASC specks ( Fig. 2d) . Of note, we did not detect processing of IL-1β or caspase-1 in the cytosol of LPS-primed, ATP-activated Asc −/− macrophages ( Fig. 2d) .
To assess whether ASC specks are also able to process mature IL-1β from its precursor form when it is released from cells, we next generated cell-free supernatants from resting macrophages or macrophages in which inflammasomes were activated. To additionally assess the role of caspase-1 present on the speck in this process, we isolated ASC specks from wild-type or Casp1 −/− macrophages and incubated them at 37 °C with cell-free supernatants of macrophages in which inflammasomes were activated. We observed that both wild-type ASC specks and Casp1 −/− ASC specks promoted further cleavage of pro-IL-1β that had been released from cells in which inflammasomes were activated ( Supplementary Fig. 3a) . These data showed that ASC specks were able to induce the processing of pro-IL-1β released from cells. Additionally, the finding that pro-IL-1β was also processed when Casp1 −/− ASC specks were added to supernatants suggested that these specks were able to recruit and activate pro-caspase-1 from cellular supernatants, which in turn was sufficient to mediate the processing of pro-IL-1β. Indeed, Casp1 −/− ASC specks carried pro-IL-1β, which we did not observe on wild-type ASC specks ( Supplementary  Fig. 3a ). This indicated that wild-type ASC specks induced cleavage of pro-IL-1β by a process that required caspase-1 on the ASC specks. How pro-IL-1β is bound to the Casp1 −/− ASC specks remains to be investigated.
To assess whether Casp1 −/− ASC specks were indeed able to recruit and activate pro-caspase-1 from cellular supernatants, we added Casp1 −/− ASC specks to cell-free supernatants of macrophages in which inflammasomes were activated and incubated the mixture (protocol, Supplementary Fig. 3b ). We subsequently pelleted the Casp1 −/− ASC specks by centrifugation, washed them and assessed caspase-1 in the pellets. Immunoblot analysis with anti-GFP served as a loading control, since the Casp1 −/− ASC specks were isolated from ASC-FPexpressing Casp1 −/− cells. This analysis revealed that Casp1 −/− ASC specks were able to recruit and mature pro-caspase-1 released from cells in which inflammasomes were activated ( Supplementary  Fig. 3b ). Together these data showed that extracellular ASC specks were able to recruit and activate both pro-caspase-1 and pro-IL-1β in cell cytosols or cell-free supernatants.
Extracellular specks are a danger signal Phagocytosis of extracellular peptide aggregates, such as amyloid-β and islet amyloid polypeptide, can activate the NLRP3 inflammasome by inducing lysosomal damage [17] [18] [19] . Since ASC specks are large protein aggregates, this raised the possibility that they could also be sensed as a danger signal by phagocytic cells of the immune system. Indeed, we observed that macrophages ingested ASC specks, which remained stable in phagolysosomal compartments of cells over several hours before being degraded ( Fig. 3a,b) . To investigate whether the ingestion of ASC specks results in lysosomal damage, similar to what is observed with crystals or peptide aggregates 17,20-25 , we next assessed phagolysosomal stability by incubating mouse macrophages with fluorescent dextran 25 alone or together with fluorescent ASC specks or the lysosome-damaging peptide LeuLeu-OMe (l-Leucyl-L-leucine methyl ester). Incubation of macrophages with ASC specks or LeuLeu-OMe caused lysosomal swelling and leakage of fluorescent dextran into the cytosol (Fig. 3c,d) , which suggested that ASC specks were able to trigger lysosomal damage. To directly assess whether the uptake of exogenous ASC specks induces the activation of inflammasomes in phagocytic cells, we incubated macrophages expressing together with ASC specks containing ASC tagged with cyan fluorescent protein (ASC-mCerulean) so that we could simultaneously track both the added aggregated ASC specks and the soluble ASC inside macrophages. We observed that uptake of ASC-mCerulean specks by ASC-mCherry-expressing macrophages resulted in the formation of mCherry + specks within these cells ( Fig. 3e) . Consistent with that observation, ASC specks added to bone marrow-derived macrophages (BMDMs) induced IL-1β in a dose-and time-dependent manner, but the addition of a mock preparation of cytosolic lysates of Asc −/− macrophages did not ( Fig. 3f,g) . Collectively, these results indicated that macrophages in which inflammasomes were activated released ASC specks that were perceived as an endogenous danger signal with the potential to propagate inflammatory signals to the surrounding cells.
ASC specks have 'prionoid' activities
While analyzing the uptake of purified ASC-mCerulean specks added to recipient ASC-mCherry-expressing reporter macrophages by confocal microscopy (Fig. 3e) , we noticed that ASC-mCherry was recruited to a fraction of the ingested ASC-mCerulean specks (Fig. 4a) . We noted that after longer incubation periods, ASC-mCerulean specks had recruited all the soluble cytosolic ASC of the recipient ASC-mCherryexpressing reporter macrophages (Fig. 4b) . These data suggested that in addition to inducing the release of IL-1β from macrophages, extracellular ASC specks might also aggregate cytosolic soluble ASC from recipient cells after their escape from phagosomes. A similar 'seeding' activity is commonly observed with prion or 'prionoid' (prion-like) proteins, which are able to aggregate their cytosolic soluble counterparts once they escape endocytic vesicles and gain access to the host cell cytosol [26] [27] [28] . We next investigated whether ASC specks in cells or purified from activated cells display prion-like features, similar to what has been shown with other purified ASC proteins 5, 6 . Imaging of fluorescent ASC specks by confocal scanning microscopy and super-resolution stimulated emission depletion microscopy revealed the presence of long fibrillar structures (Fig. 4c,d) . We next generated recombinant ASC specks from wild-type cells or, as a control, subjected Asc −/− cells to the same protocol. Electron microscopy of ASC speck material isolated from wild-type cells revealed the presence of fibrillar structures, but we did not find such structures in such material obtained from Asc −/− cells (Fig. 4e,f) . Furthermore, ASC speck preparations obtained from ASC-FP-expressing reporter cells and stained with gold-labeled anti-GFP identified the structures as ASC specks (Fig. 4g) . Cryo-electron microscopy further confirmed the presence of fibrillar structures in ASC speck preparations isolated from macrophages (Supplementary Fig. 4a ).
Most proteins that form prions have the ability to promote their own polymerization in a process called 'seeding' , in which preformed fibers provide templates for fiber elongation. This process potentially drives prion infectivity and the development of associated diseases 26, 29, 30 . To assess the propensity of purified ASC specks isolated from cells to act as a 'seed' for the further aggregation of soluble ASC in more detail, we added ASC-mCerulean specks to soluble cytosolic extracts of ASC-mCherry-expressing cells and examined the recruitment of the soluble ASC-mCherry to ASC-mCerulean specks over time. This analysis revealed that ASC specks recruited soluble ASC within seconds ( Supplementary Fig. 4b and Supplementary Movie 6) , which led to the formation of an outer layer of ASC-mCherry around a core of ASC-mCerulean (Supplementary Fig. 4c ). Moreover, we were also able to monitor the rapid recruitment of soluble ASC-mCherry to ASC-mCerulean specks by flow cytometry (Supplementary Fig. 4d ). Of note, ASC was specifically required for nucleation of its soluble counterpart, since soluble protein of the crystallizable fragment Fc tagged with mCherry was not aggregated by incubation with ASC-mCerulean specks (Supplementary Fig. 4e ). Hence, these data suggested that ASC specks isolated from cells acted as a 'seed' to further aggregate soluble ASC in a cell-free system or within cytosols after npg A r t i c l e s ASC specks escaped from the phagosome. These features are shared with other prionoid proteins 26 , and these data suggested that ASC specks were able to 'infect' bystander cells and propagate the nucleation of soluble ASC.
ASC specks induce inflammatory responses in vivo
Activation of the NLRP3 inflammasome in vivo results in the recruitment of neutrophils and inflammatory monocytes by a mechanism largely dependent on the receptor for IL-1 (IL-1R) 20, 21 . To assess the ASC speck-induced inflammatory response in vivo, we injected fluorescent ASC specks or, as a control, fluorescent beads into the ears of mice and visualized subdermal recruitment of neutrophils in two different mouse models. The first model used mice heterozygous for a transgene encoding enhanced GFP inserted into the gene encoding lysozyme (which results in GFP + granulocytes and macrophages). We found that injection of ASC specks led to more recruitment of GFP + neutrophils in these reporter mice than did injection of fluorescent beads (Fig. 5a) . We next examined the recruitment of neutrophils after the injection of ASC specks into the ear subdermis of wild-type mice. The injection of ASC specks into these mice enhanced neutrophil diapedesis and attachment of neutrophils to venules in areas near the deposited ASC specks; diapedesis of neutrophils was lower in the same areas in mice given injection of fluorescent beads ( Fig. 5b) . Of note, microscopy of the subdermal injection site for up to 96 h revealed that injected ASC specks remained visible (Supplementary Fig. 5a ), which indicated that they were resistant to extracellular proteases. Such protease insensitivity can typically be observed with other prionoid proteins 27, 28, 31 . Consistent with the inflammatory properties of ASC specks injected into the subdermis, intraperitoneal injection of ASC specks into wild-type mice promoted the development of a sterile peritonitis characterized by the recruitment of neutrophils and inflammatory monocytes (Fig. 5c) . The recruitment of these inflammatory cells after the injection of ASC specks was partially impaired in Nlrp3 −/− mice and was entirely blocked in IL-1R-deficient (Il1r1 −/− ) mice ( Fig. 5d) , which indicated that ASC specks elicited the maturation of IL-1β in vivo. Furthermore, these data suggested that ASC specks were able to induce activation of caspase-1 in an NLRP3-independent manner, probably due to the propensity of ASC specks to directly recruit ASC and activate caspase-1 in cells that ingested ASC specks. Consistent with NLRP3-independent activation of caspase-1 in vivo, the in vitro IL-1β response to ASC specks was not significantly lower in Nlrp3 −/− BMDMs than in wild-type cells, but it was dependent on ASC and caspase-1 (Fig. 5e) . Thus, ASC specks caused inflammatory responses in vivo and in vitro, and the activation of IL-1β was not fully dependent on the activation of inflammasomes by NLRP3.
Extracellular specks accumulate in inflammatory disease
We next investigated whether the activation of inflammasomes in vivo led to the appearance of extracellular ASC specks. Immunostaining of fixed and permeabilized lymph node sections revealed that ASC specks were present in most subcapsular macrophages after infection with P. aeruginosa (Fig. 1b) . To investigate whether such infection would also induce the appearance of extracellular ASC specks in vivo, we modified the detection protocol and first infected mice by injection of P. aeruginosa into the footpad, followed by injection of anti-ASC, 4 h later, via the same route. This procedure could stain ASC specks appearing in the extracellular space (in the absence of detergents). We then collected the draining popliteal lymph nodes and visualized npg by confocal microscopy sections stained with fluorescent secondary antibody. Indeed, by this technique we detected extracellular ASC specks in the subcapsular macrophage area of infected lymph nodes (Fig. 6a) . In contrast, we found no staining in the same area of lymph nodes obtained from mock-infected mice (i.e., those given injection of PBS) (Fig. 6a) . As P. aeruginosa is a known activator of the NLRC4 inflammasome 32 , these data suggested that in vivo activation of the NLRC4 inflammasome also resulted in the release of ASC specks into the extracellular space. Furthermore, these data showed that ASC specks were accessible to antibodies in vivo after the activation of inflammasomes. We confirmed that anti-ASC specifically stained ASC specks deposited in tissues (Supplementary Fig. 5b) .
Our data showing a role for extracellular ASC specks in driving inflammatory responses opened the possibility that ASC specks might be able to accumulate in inflamed tissues. Chronic obstructive pulmonary disease (COPD) is an inflammatory airway disease in which activation of inflammasomes is thought to have a role 33, 34 . COPD develops because of chronic inflammatory responses to noxious particles or gases in lung tissues. To test the hypothesis that ASC specks accumulate during chronic lung inflammation, we made use of a mouse model of smoke-induced COPD, in which mice develop hallmark features of the human disease 35 . We exposed mice to air or cigarette smoke 5 d a week for a total of 8 weeks, after which we collected BALF. We were able to quantify ASC specks by flow cytometry after staining them with two different monoclonal antibodies to ASC, each labeled with a different fluorescent dye (Fig. 6b) . By this method, we observed that mice that inhaled cigarette smoke for 8 weeks had significantly more extracellular ASC specks in their BALF than did mice exposed to air for the same period (Fig. 6c) . These data indicated that ASC specks may be part of a chronic inflammatory response to smoke-induced damage to cells and tissues. We next attempted to identify ASC specks in BALF from healthy human subjects or patients with COPD, pneumonia or pulmonary hypertension. Untreated BALF samples from patients contained a large number of cells (Fig. 6d) . Therefore, we removed cells by centrifugation at 400g and further filtered the supernatants through 5-µm filters, similar to the protocol established to separate ASC specks from cellular debris in cell culture supernatants (Supplementary Fig. 1b) . This procedure yielded cell-free BALF, yet the smaller material was still available for further analysis in the filtrate (Fig. 6d) . To investigate whether extracellular ASC specks found in BALF obtained from humans was in an active state (i.e., containing ASC monomers, dimers and oligomers), we pelleted the filtrates by centrifugation and crosslinked the ASC in the filtrate with DSS (Fig. 6e) . This analysis revealed that BALF npg A r t i c l e s from patients with COPD and pneumonia contained extracellular preassembled ASC specks, while BALF from patients with pulmonary hypertension or from healthy donors did not (Fig. 6e) . As a positive control, we used cell-free supernatants of THP-1 cells in which the NLRP3 inflammasome was activated (Fig. 6e) . Together these data showed that ASC specks were present in the extracellular space in lungs from patients with inflammatory pulmonary disease and suggested that these specks could be part of the chronic inflammatory response observed in such patients.
Anti-ASC opsonizes ASC specks and increases inflammation
We next sought to investigate whether extracellular ASC specks modify the inflammatory response after activation of inflammasomes in vivo. We injected anti-ASC or purified immunoglobulin G (IgG) into mice intravenously and subsequently induced peritonitis by intraperitoneal injection of silica crystals. The systemically available anti-ASC should bind to the extracellular ASC specks that appear after in vivo activation of inflammasomes and thereby alter the biological response. Indeed, mice treated with anti-ASC before activation of inflammasomes by intraperitoneal injection of silica crystals had much more recruitment of neutrophils and inflammatory monocytes to the peritoneum than did mice treated with the IgG control antibody (Fig. 7a) . These data confirmed that ASC specks were released after activation of inflammasomes in vivo and became accessible to anti-ASC. The enhanced inflammatory response in vivo to silica crystals in the presence of anti-ASC indicated that anti-ASC might opsonize ASC specks and thereby induce enhanced inflammation. To assess this, we preincubated fluorescent ASC specks with anti-ASC or anti-GFP and compared their uptake by macrophages. We found that antibody-opsonized ASC specks were taken up more efficiently by macrophages than were ASC specks that had not been opsonized by antibodies ( Fig. 7b-d) . Consistent with those results, opsonization of ASC specks by antibodies enhanced the release of IL-1β from macrophages (Fig. 7e) . Together these data suggested that anti-ASC contributed to the inflammatory responses by opsonizing ASC specks.
Several autoantibodies have been shown to have inflammatory properties, as they can increase the cellular uptake of inflammatory material (such as DNA or RNA) as immunocomplexes. In fact, this inflammatory nature is believed to be part of the pathogenesis of autoantibody-mediated inflammation 36 . Therefore, it is conceivable that patients with autoimmune diseases have autoantibodies to extracellular ASC. To test this hypothesis, we obtained serum from patients with autoimmune disease and high titers of antinuclear antibody (ANA + ) and screened the serum by flow cytometry to assess the presence of antibodies that react to ASC specks. Indeed, among the ANA + patients tested, 18% had antibodies that reacted to ASC specks (Fig. 7f) . We then used an enzyme-linked immunosorbent assay (ELISA) to confirm that the serum was positive for anti-ASC specks (Supplementary Fig. 6a ). Next, we assessed whether antibodies to ASC specks would also develop in mice with experimental lupus 37 . Similar to results obtained for serum from patients with autoimmune disease, we also detected autoantibodies reactive to ASC specks in serum from mice with experimental lupus (Supplementary  Fig. 6b) . These data suggested that ASC specks might be opsonized by autoantibodies and that this might contribute to the inflammatory npg response. To test this hypothesis, we incubated ASC specks with serum from autoimmune mice before adding them to LPS-primed BMDMs and found that they boosted IL-1β responses in these recipient cells to an extent similar to that achieved by purified commercially available anti-ASC ( Fig. 7g) . We did not observe this effect when we incubated ASC specks with serum from healthy control mice (Fig. 7g) .
Together these data suggested that antibodies to ASC were present in inflammatory diseases and might potentially exacerbate the effects of extracellular ASC specks.
DISCUSSION
The activation of inflammasomes induces the rapid polymerization of ASC and caspase-1 into a fibrillar signaling platform. Similar processes can be found in other signaling pathways [38] [39] [40] , and it is thought that these functional protein fibrils favor 'digital' on-off responses that lead to the cleavage and release of caspase-1 substrates. Since the activation of caspase-1 also results in cell death [4] [5] [6] , each activated cell can respond only once. Thus, the inflammatory output of the individual cell in which inflammasomes are activated would thus depend solely on the available cellular pool of caspase-1 substrates. Such a one-time response would greatly limit the possible inflammatory output of cells in which inflammasomes are activated. Our study has revealed previously unappreciated extracellular activities of ASC specks that persisted even after the demise of the activated cell. The ability of ASC specks to mature caspase-1 and its substrates in the extracellular space might contribute to a 'depot effect' of inflammasomes and lead to prolonged inflammatory activity. Furthermore, we found that ASC specks were recognized as a danger signal akin to other aggregated substances; this cell-to-cell transfer of aggregated ASC leading to new cellular signaling represents an additional cell-to-cell communication mechanism. The seeding activity and fibrillar structure of ASC specks is reminiscent of that of prion proteins, which propagate from cell to cell in an aggregated protein state 27, 28, 31 . Prion proteins can induce the conversion of correctly folded proteins to prions that accumulate and eventually cause diseases 27, 28, 31 . Some prion proteins misfold into a characteristic amyloid fold. However, our extensive attempts to identify amyloid folds in ASC specks were negative, which suggests that ASC specks are not true amyloid proteins but instead have prion-like activities. Another feature of prions is their resistance to proteases. npg Indeed, we observed that ASC specks remained visible for prolonged periods of time after injection into tissues. The deposition of ASC specks in tissues induced the recruitment of neutrophils. After their recruitment to the endangered tissues, neutrophils can amplify tissue inflammation as they degranulate and release various inflammatory mediators, enzymes and danger signals. Of note, neutrophils can carry ASC and caspase-1 in secretory vesicles and tertiary granule compartments, which are released upon activation 41 . Since ASC specks can recruit soluble ASC and activate caspase-1, neutrophilderived ASC or caspase-1 may thereby further contribute to the inflammatory milieu. It is conceivable that an extracellular function of inflammasomes has evolved to enhance and to focus the inflammatory tissue reaction to the site of injury. On the other hand, the failure to appropriately clear ASC specks in inflamed tissues could lead to the accumulation of ASC specks and the subsequent perpetuation of immune responses. In agreement with this hypothesis, the presence of ASC and other inflammasome components in cerebrospinal fluid correlates with poor outcomes in patients with brain injury 42 .
Typically, large doses of aggregated or crystalline substances are required for activation of the NLRP3 inflammasome. We thus hypothesize that the NLRP3-activation threshold, combined with the ability of macrophages to degrade subthreshold amounts of ASC specks, would limit the spread of inflammation and lead to a concentrationdependent effect. Additionally, the activity of caspase-1 is sensitive to oxidation, which could block the enzymatic function of extracellular specks 43 . Consistent with the proposal of an activation threshold by which extracellular ASC specks are recognized by cells, antibodycoated ASC specks were ingested more efficiently than were untreated ASC specks. The coating of ASC specks with anti-ASC resulted in more production of IL-1β by recipient cells in vitro and an enhanced inflammatory response to the activation of inflammasomes in vivo.
Our finding of autoantibodies to ASC specks in a large percentage of patients with autoimmune disease warrants further studies of larger populations. Additionally, whether autoantibodies to ASC specks are associated with inflammatory pathologies remains to be investigated. The finding that treatment with anti-ASC altered the in vivo inflammatory response to crystals suggests that extracellular ASC specks appear after the activation of inflammasomes and opens the possibility that therapies directed against ASC specks could modulate inflammation. So far, only inflammasome effector molecules, such as IL-1β and IL-18, or their receptors have been targeted for pharmaceutical intervention. Indeed, this idea is supported by studies of models of traumatic brain injury and spinal cord injury showing that anti-ASC therapy is able to reduce the activation of caspase-1 and IL-1β and result in reduced tissue damage 44, 45 . However, as shown by our in vivo studies with anti-ASC, different antibodies can have contrasting effects, which warrants careful design and selection of the antibodies to ASC for future therapeutic use. For example, modern antibody-engineering techniques allow the production of antibodies that do not interact with Fc receptors. In addition, antibodies that interfere with the ASC speck-mediated maturation of extracellular caspase-1 or IL-1β could be generated, and hence different activities of ASC specks could be targeted therapeutically.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
Production and purification of ASC specks. ASC specks were assembled in vitro by incubation of cytosolic extracts for 45 min at 37 °C ( Supplementary  Fig. 2c ) or were purified from LPS-primed cells activated with ATP or nigericin, as described 4, 47 . The ASC specks were further passed through a 'cushion' of 50% Percoll in CHAPS buffer (20 mM HEPES-KOH, pH 7.5, 5 mM MgCl 2 , 0.5 mM EGTA, 0.1 mM PMSF and 0.1% CHAPS) for purification as described 47 (Supplementary Fig. 2d ). For imaging by electron microscopy, fluorescent ASC specks were further sorted by flow cytometry before analysis. For investigation of the oligomerization of ASC, ASC specks were washed with 0.5 ml CHAPS buffer and were chemically crosslinked for 30 min at room temperature with 2 mM DSS (Pierce) prior to immunoblot analysis.
Immunoblot analysis. Proteins were separated by 4-12% SDS-PAGE in precast gels (Novex, Invitrogen) with MES or MOPS buffer (Novex, Invitrogen). Proteins were then transferred onto PVDF membranes (Millipore) and nonspecific binding was blocked with 3% BSA in Tris-buffered saline containing 0.1% Tween-20, followed by overnight incubation with specific primary antibodies (identified above). Membranes were then washed and were incubated with the appropriate secondary antibodies (coupled to IRDye 800CW or IRDye 680RD; 1:15,000 dilution; LI-COR Biosciences), and immunoreactivity was observed by near-infrared detection, followed by analysis with an Odyssey CLx imaging system (LI-COR Biosciences).
Confocal microscopy.
A Leica TCS SP5 SMD confocal system (Leica Microsystems) was used for confocal laser-scanning microscopy. For live imaging, the temperature was maintained at 37 °C with 5% CO 2 through the use of an environmental control chamber (Life Imaging Services and Solent Scientific). Images were acquired at various time points with a 63× objective, followed by analysis with the Leica Application Suite Advanced Fluorescence imaging platform, version 2.2.1 (Leica Microsystems), or Volocity 6.01 software. A Leica TCS STED microscope was used for stimulated emission-depletion imaging. ASC specks purified from activated macrophages npg
